Cap. 18. Southern Europe

Autor: Castelli, F, Pavli, A, Giorgetti, Pf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3662::7e66774e6b4bf8e64c213ea442cc5e8e
http://hdl.handle.net/11379/532616

Rischio di colera nei viaggiatori. Percezione, realtà e prevenzione

Autor: Caligaris, S, Rodari, P, Giorgetti, Pf, Autino, B, Buelli, F, Castelli, Francesco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3662::6e9c3048478f0c741d809c194f45ad3d
http://hdl.handle.net/11379/43977

Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study.

Autor: Elsinga J; Luxembourg Operational Research Unit, Médecins Sans Frontières, Luxembourg City, Luxembourg; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Sunyoto T; Luxembourg Operational Research Unit, Médecins Sans Frontières, Luxembourg City, Luxembourg. Electronic address: temmy.sunyoto@brussels.msf.org., di Stefano L; Operational Centre Belgium, Médecins Sans Frontières, Brussels, Belgium., Giorgetti PF; Médecins Sans Frontières Nigeria, Abuja, Nigeria., Kyi HA; Médecins Sans Frontières Nigeria, Abuja, Nigeria., Burzio C; Operational Centre Belgium, Médecins Sans Frontières, Brussels, Belgium., Campos Moreno X; Operational Centre Belgium, Médecins Sans Frontières, Brussels, Belgium., Ojide CK; Alex Ekwueme Federal University Teaching Hospital, Federal Ministry of Health, Abakaliki, Nigeria., Ajayi N; Alex Ekwueme Federal University Teaching Hospital, Federal Ministry of Health, Abakaliki, Nigeria., Ewah R; Alex Ekwueme Federal University Teaching Hospital, Federal Ministry of Health, Abakaliki, Nigeria., Ogah EO; Alex Ekwueme Federal University Teaching Hospital, Federal Ministry of Health, Abakaliki, Nigeria., Dan-Nwafor C; Nigerian Center for Disease Control and Prevention, Abuja, Nigeria., Ahumibe A; Nigerian Center for Disease Control and Prevention, Abuja, Nigeria., Ochu CL; Nigerian Center for Disease Control and Prevention, Abuja, Nigeria., Olayinka A; Nigerian Center for Disease Control and Prevention, Abuja, Nigeria., Jonckheere S; Operational Centre Belgium, Médecins Sans Frontières, Brussels, Belgium., Chaillet P; Operational Centre Belgium, Médecins Sans Frontières, Brussels, Belgium., van Herp M; Operational Centre Belgium, Médecins Sans Frontières, Brussels, Belgium.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Sep; Vol. 24 (9), pp. 1037-1044. Date of Electronic Publication: 2024 May 08.

Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study.

Autor: Sane Schepisi M; Clinical Epidemiology Unit, National Institute for Infectious Diseases L. Spallanzani - IRCCS, Rome, Italy., Navarra A; Clinical Epidemiology Unit, National Institute for Infectious Diseases L. Spallanzani - IRCCS, Rome, Italy., Altet Gomez MN; Unidad de Tratamiento Directamente Observado de la Tuberculosis 'Servicios Clínicos,' Barcelona, Spain., Dudnyk A; Tuberculosis, Clinical Immunology & Allergy Department, National Pirogov Memorial Medical University, Vinnytsia, Ukraine., Dyrhol-Riise AM; Department of Infectious Diseases, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Department of Clinical Science, University of Bergen, Norway., Esteban J; Departamento de Microbiología Clínica, Fundación Jiménez Díaz, Madrid, Spain., Giorgetti PF; Clinica di Malattie Infettive e Tropicali, A. O. Spedali Civili di Brescia e Università di Brescia, Brescia, Italy., Gualano G; Clinical Department, National Institute for Infectious Diseases L. Spallanzani - IRCCS, Rome, Italy., Guglielmetti L; Sanatorium, Centre Hospitalier de Bligny Briis-sous-Forges, Paris, France.; APHP, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (CNR-MyRMA), Bactériologie-Hygiène, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France.; Sorbonne Université, Unité 1135, Team E13 (Bactériologie), CR7 INSERM, Centre d'Immunologie et des Maladies Infectieuses, Paris, France., Heyckendorf J; Research Center Borstel. German Center for Infection Research (DZIF), Borstel, Germany., Kaluzhenina A; Department of Phthisiopulmonology, Volgograd State Medical University, Volgograd, Russian Federation., Lange B; Infectious Disease Division, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.; Center for Chronic Immunodeficiency, Faculty of Medicine, Medical Center, University of Freiburg, Germany., Lange C; Research Center Borstel. German Center for Infection Research (DZIF), Borstel, Germany., Manika K; Respiratory Infections Unit, Pulmonary Department, Aristotle University of Thessaloniki, 'G. Papanikolaou' Hospital, Thessaloniki, Greece., Miah J; Division of Infection, Barts Health NHS Trust, London, United Kingdom., Nanovic Z; Institute of Lung Diseases and Tuberculosis - Skopje, Institute of Lung Diseases and Tuberculosis - Skopje, Skopje, FYROM (Macedonia)., Pontali E; Divisione di Malattie Infettive, Ospedale Galliera - Genova, Genova, Italy., Prego MR; Enfermedades Infecciosas, Medicina Interna, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., Solovic I; Catholic University Ruzomberok, Slovakia., Tiberi S; Division of Infection, Barts Health NHS Trust, London, United Kingdom., Palmieri F; Clinical Department, National Institute for Infectious Diseases L. Spallanzani - IRCCS, Rome, Italy., Girardi E; Clinical Epidemiology Unit, National Institute for Infectious Diseases L. Spallanzani - IRCCS, Rome, Italy.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2018 Dec 19; Vol. 6 (1), pp. ofy337. Date of Electronic Publication: 2018 Dec 19 (Print Publication: 2019).

Policies and practices on the programmatic management of LTBI: a survey in the African Region.

Autor: Sulis G; University Department of Infectious and Tropical Diseases & World Health Organization Collaborating Centre for TB/HIV and TB Elimination University of Brescia, Brescia, Italy; McGill International TB Centre, McGill University, Montréal, Quebec, Canada., Carvalho ACC; Laboratory of Innovation in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil., Capone S; University Department of Infectious and Tropical Diseases & World Health Organization Collaborating Centre for TB/HIV and TB Elimination University of Brescia, Brescia, Italy., Hamada Y; TB/HIV and Community Engagement Unit, Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Giorgetti PF; University Department of Infectious and Tropical Diseases & World Health Organization Collaborating Centre for TB/HIV and TB Elimination University of Brescia, Brescia, Italy., da Silva Martins P; Laboratory of Innovation in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil., Getahun H; TB/HIV and Community Engagement Unit, Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Matteelli A; University Department of Infectious and Tropical Diseases & World Health Organization Collaborating Centre for TB/HIV and TB Elimination University of Brescia, Brescia, Italy.

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2018 Feb 01; Vol. 22 (2), pp. 158-164.